nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.08.2008 | Original Paper

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer

verfasst von: M. Schrauder, S. Frank, P. L. Strissel, M. P. Lux, M. R. Bani, C. Rauh, C. C. Sieber, K. Heusinger, A. Hartmann, R. Schulz-Wendtland, R. Strick, M. W. Beckmann, Peter A. Fasching

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Various ATM (ataxia telangiectasia-mutated) mutations and polymorphisms have been reported to be associated with an increased breast cancer risk. Recent studies have produced contradictory results regarding the association between ATM genetic variants and breast cancer risk.

Materials and methods

The common ATM polymorphism 5557G>A (p.D1853N) (rs1801516), previously suggested to be associated with bilateral breast cancer, was analyzed using real-time PCR in 514 unselected patients with breast cancer and 511 age-matched healthy control individuals. DNA was obtained from peripheral blood draw.

Results

The ATM genotype was weakly associated with the risk for breast cancer (P = 0.04 for the overall test). The odds ratio for women with a heterozygous genotype was 0.70 (95% CI, 0.52–0.94) and for the homozygous variant 0.63 (95% CI, 0.27–1.49). Disease-free survival and overall survival showed no significant association with specific genotypes.

Conclusions

The results of this study might suggest a minor association between polymorphism 5557G>A and a reduced risk of breast cancer

Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717–8725PubMed

Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190–202PubMedCrossRef

Bakkenist CJ, Kastan MB (2004) Initiating cellular stress responses. Cell 118:9–17PubMedCrossRef

Bebb DG, Yu Z, Chen J, Telatar M, Gelmon K, Phillips N, Gatti RA, Glickman BW (1999) Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer. Br J Cancer 80:1979–1981PubMedCrossRef

Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P (2006) Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066–6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat 27:1122–1128PubMedCrossRef

Blamey RW, Cataliotti L (2006) EUSOMA accreditation of breast units. Eur J Cancer 42:1331–1337PubMedCrossRef

Borresen AL, Andersen TI, Tretli S, Heiberg A, Moller P (1990) Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2:339–340PubMedCrossRef

Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE, van’t Veer LJ (2000) ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66:494–500PubMedCrossRef

Cavaciuti E, Lauge A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N (2005) Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer 42:1–9PubMedCrossRef

Dork T, Bendix R, Bremer M, Rades D, Klopper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH (2001) Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 61:7608–7615PubMed

Einarsdottir K, Rosenberg LU, Humphreys K, Bonnard C, Palmgren J, Li Y, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedren S (2006) Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case–control and follow-up study. Breast Cancer Res 8:R67PubMedCrossRef

Eyfjord JE, Bodvarsdottir SK (2005) Genomic instability and cancer: networks involved in response to DNA damage. Mutat Res 592:18–28PubMed

FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307–310PubMedCrossRef

Gatti RA, Tward A, Concannon P (1999) Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 68:419–423PubMedCrossRef

Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Nieminen P, Winqvist R (2005) Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer 116:69–72PubMedCrossRef

Kurz EU, Lees-Miller SP (2004) DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3:889–900CrossRef

Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P (2006) On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer 119:724–725PubMedCrossRef

Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD Jr, Tucker M (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 93:121–127PubMedCrossRef

Olsen JH, Hahnemann JM, Borresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarstrom L, Robsahm TE, Kaariainen H, Bregard A, Brondum-Nielsen K, Yuen J, Tucker M (2005) Breast and other cancers in 1,445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br J Cancer 93:260–265PubMedCrossRef

Platzer M, Rotman G, Bauer D, Uziel T, Savitsky K, Bar-Shira A, Gilad S, Shiloh Y, Rosenthal A (1997) Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7:592–605PubMed

Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P (2007) The role of ATM in breast cancer development. Breast Cancer Res Treat 104(2):121–128PubMedCrossRef

Ralhan R, Kaur J, Kreienberg R, Wiesmuller L (2007) Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett 248(1):1–17PubMedCrossRef

Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38:873–875PubMedCrossRef

Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155–168PubMedCrossRef

Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31:402–410PubMedCrossRef

Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ (2006) The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat 27:538–544PubMedCrossRef

Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT (1986) The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 39:573–583PubMed

Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289–1294PubMedCrossRef

Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831–1836PubMedCrossRef

Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, Concannon P (2001) Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 92:479–487PubMedCrossRef

Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97:813–822PubMedCrossRef

Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomaki K, Blomqvist C, Borresen-Dale AL, Nevanlinna H (2006) ATM variants and cancer risk in breast cancer patients from Southern Finland. BMC Cancer 6:209PubMedCrossRef

Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Nehls M, Boehm T, Rosenthal A, Shiloh Y, Rotman G (1996) Genomic Organization of the ATM gene. Genomics 33:317–320PubMedCrossRef

Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434–442PubMed

Titel: Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer
verfasst von: M. Schrauder
S. Frank
P. L. Strissel
M. P. Lux
M. R. Bani
C. Rauh
C. C. Sieber
K. Heusinger
A. Hartmann
R. Schulz-Wendtland
R. Strick
M. W. Beckmann
Peter A. Fasching
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2008
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-008-0355-9

Springer Medizin

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer